Abstract
PURPOSE: Recently, TSLC1 (tumor suppressor in lung cancer 1) gene has been identified as a novel tumor suppressor in human non-small cell lung cancers. The clinical relevance of TSLC1 gene expression has never been studied using patients’ data and surgical samples. The present study was designed to evaluate whether the TSLC1 gene can be serve a target for a prognostic determinant of patients with pulmonary adenocarcinomas.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
